Altogether, these data suggest that, upon ectopic expression, NSD2 assists oncogenic transcription factors (namely FOXA1 and HOXB13) in expanding the AR enhancer circuitry to include chimeric AR half-sites that constitute over two-thirds of PCa AR cistromes. The gene discussed is AR; the disease is posterior cortical atrophy.